These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2997428)
1. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. Darius H; Smith JB; Lefer AM J Pharmacol Exp Ther; 1985 Nov; 235(2):274-81. PubMed ID: 2997428 [TBL] [Abstract][Full Text] [Related]
2. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor. Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Heikes JE; Sprague PW; Antonaccio MJ Prostaglandins; 1981 Aug; 22(2):295-307. PubMed ID: 6270744 [TBL] [Abstract][Full Text] [Related]
3. Antiaggregatory effects of thromboxane receptor antagonists in vivo. Darius H; Lefer AM Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552. Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833 [TBL] [Abstract][Full Text] [Related]
5. Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle. Harris DN; Greenberg R; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Steinbacher TE Eur J Pharmacol; 1984 Aug; 103(1-2):9-18. PubMed ID: 6090180 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo. Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188 [TBL] [Abstract][Full Text] [Related]
7. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. Fitzgerald DJ; Doran J; Jackson E; FitzGerald GA J Clin Invest; 1986 Feb; 77(2):496-502. PubMed ID: 3003161 [TBL] [Abstract][Full Text] [Related]
8. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice. Darius H; Lefer AM Proc Soc Exp Biol Med; 1985 Nov; 180(2):364-8. PubMed ID: 2996012 [TBL] [Abstract][Full Text] [Related]
9. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. Carmo LG; Hatmi M; Rotilio D; Vargaftig BB Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist. Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108 [TBL] [Abstract][Full Text] [Related]
12. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro. De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist. Perzborn E; Fiedler VB; Seuter F; Stasch JP; Weber H; Sander E; Böshagen H; Rosentreter U Stroke; 1990 Dec; 21(12 Suppl):IV143-5. PubMed ID: 2148034 [TBL] [Abstract][Full Text] [Related]
14. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro. Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog. Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Steinbacher TE; Ogletree ML; Hall SE Prostaglandins; 1986 Apr; 31(4):651-67. PubMed ID: 3088677 [TBL] [Abstract][Full Text] [Related]
16. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism. Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr. Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367 [TBL] [Abstract][Full Text] [Related]